Published in Neurology on March 22, 2005
Serum urate as a predictor of clinical and radiographic progression in Parkinson disease. Arch Neurol (2008) 2.79
Dietary and lifestyle variables in relation to incidence of Parkinson's disease in Greece. Eur J Epidemiol (2013) 1.72
Diet, urate, and Parkinson's disease risk in men. Am J Epidemiol (2008) 1.69
Midlife milk consumption and substantia nigra neuron density at death. Neurology (2015) 1.51
Consumption of dairy products and risk of Parkinson's disease. Am J Epidemiol (2007) 1.23
Urate: a novel biomarker of Parkinson's disease risk, diagnosis and prognosis. Biomark Med (2010) 1.13
Developmental heptachlor exposure increases susceptibility of dopamine neurons to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)in a gender-specific manner. Neurotoxicology (2008) 0.96
Meeting report: consensus statement-Parkinson's disease and the environment: collaborative on health and the environment and Parkinson's Action Network (CHE PAN) conference 26-28 June 2007. Environ Health Perspect (2008) 0.94
The association between Mediterranean diet adherence and Parkinson's disease. Mov Disord (2012) 0.88
Dairy foods intake and risk of Parkinson's disease: a dose-response meta-analysis of prospective cohort studies. Eur J Epidemiol (2014) 0.86
Milk: an epigenetic amplifier of FTO-mediated transcription? Implications for Western diseases. J Transl Med (2015) 0.85
Relationship of Mediterranean diet and caloric intake to phenoconversion in Huntington disease. JAMA Neurol (2013) 0.83
Brain organochlorines and Lewy pathology: the Honolulu-Asia Aging Study. Mov Disord (2012) 0.81
Inverse associations of outdoor activity and vitamin D intake with the risk of Parkinson's disease. J Zhejiang Univ Sci B (2014) 0.79
Increased risk of Parkinson disease in patients with carbon monoxide intoxication: a population-based cohort study. Medicine (Baltimore) (2015) 0.77
Intake of dairy foods and risk of Parkinson disease. Neurology (2017) 0.75
Low dietary vitamin D in mid-life predicts total mortality in men with hypertension: the Honolulu heart program. J Am Coll Nutr (2014) 0.75
Parkinson's disease: no milk today? Front Neurol (2014) 0.75
Micronutrients and Risk of Parkinson's Disease: A Systematic Review. Gerontol Geriatr Med (2016) 0.75
Milk's Role as an Epigenetic Regulator in Health and Disease. Diseases (2017) 0.75
Targeting urate to reduce oxidative stress in Parkinson disease. Exp Neurol (2017) 0.75
Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke (1991) 22.23
The use of analytical isoelectric focusing for detection and identification of beta-lactamases. J Gen Microbiol (1975) 19.91
Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med (1982) 8.62
Effects of beta-lactamase from gram-negative organisms on cephalosporins and penicillins. Antimicrob Agents Chemother (Bethesda) (1968) 8.23
Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med (1987) 8.09
Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst (1993) 7.87
Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA (2008) 7.84
Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA (1986) 7.23
Evaluation of chest pain in the emergency department. Ann Intern Med (1994) 7.12
Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology (2006) 6.86
Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study. Lancet (2001) 6.67
Midlife hand grip strength as a predictor of old age disability. JAMA (1999) 6.23
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study. N Engl J Med (1984) 5.02
Noninvasive imaging of in vivo blood flow velocity using optical Doppler tomography. Opt Lett (1997) 4.48
Prevalence of dementia in older Japanese-American men in Hawaii: The Honolulu-Asia Aging Study. JAMA (1996) 4.40
Phase-resolved optical coherence tomography and optical Doppler tomography for imaging blood flow in human skin with fast scanning speed and high velocity sensitivity. Opt Lett (2000) 4.33
Effects of walking on mortality among nonsmoking retired men. N Engl J Med (1998) 4.33
Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol Aging (2000) 4.22
Maintaining mobility in late life. I. Demographic characteristics and chronic conditions. Am J Epidemiol (1993) 3.74
Frequency and characteristics of silent dementia among elderly Japanese-American men. The Honolulu-Asia Aging Study. JAMA (1997) 3.55
Frequency of bowel movements and the future risk of Parkinson's disease. Neurology (2001) 3.50
The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. JAMA (1995) 3.39
The detection of dementia in the primary care setting. Arch Intern Med (2000) 3.39
Affinities of penicillins and cephalosporins for the penicillin-binding proteins of Escherichia coli K-12 and their antibacterial activity. Antimicrob Agents Chemother (1979) 3.27
Two-dimensional birefringence imaging in biological tissue by polarization-sensitive optical coherence tomography. Opt Lett (1997) 3.18
CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study. Neurology (2003) 3.18
Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J Clin Invest (1996) 3.13
The dynamics of alcohol and marijuana initiation: patterns and predictors of first use in adolescence. Am J Public Health (2000) 3.11
Race and sex differences in hip fracture incidence. Am J Public Health (1984) 3.07
Beta-lactamase assays. Methods Enzymol (1975) 3.06
Comparison of assay techniques for beta-lactamase activity. Anal Biochem (1973) 2.96
Iodination defect in the leukocytes of a patient with chronic granulomatous disease of childhood. N Engl J Med (1969) 2.92
Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA (2000) 2.89
Competition of beta-lactam antibiotics for the penicillin-binding proteins of Pseudomonas aeruginosa, Enterobacter cloacae, Klebsiella aerogenes, Proteus rettgeri, and Escherichia coli: comparison with antibacterial activity and effects upon bacterial morphology. Antimicrob Agents Chemother (1979) 2.89
Smoking and mortality among older men and women in three communities. N Engl J Med (1991) 2.86
DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology (2007) 2.86
Physical performance measures in aging research. J Gerontol (1989) 2.86
Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315. Int J Radiat Oncol Biol Phys (1992) 2.84
Developmental risk factors for youth violence. J Adolesc Health (2000) 2.81
Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study. Am J Epidemiol (1993) 2.67
High density lipoprotein cholesterol and mortality. The Framingham Heart Study. Arteriosclerosis (1989) 2.65
Optical Doppler tomographic imaging of fluid flow velocity in highly scattering media. Opt Lett (1997) 2.64
Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study. Neurology (1992) 2.64
beta(2)-Glycoprotein 1-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction: the honolulu heart program. Stroke (2001) 2.60
Childhood and adolescent predictors of alcohol abuse and dependence in young adulthood. J Stud Alcohol (2001) 2.59
Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study. Neurology (2002) 2.42
Purification of beta-lactamases on QAE-sephadex. Biochim Biophys Acta (1973) 2.41
Participation in a clinical trial: the patients' point of view. Control Clin Trials (1985) 2.41
Hyponatremia: evaluating the correction factor for hyperglycemia. Am J Med (1999) 2.30
Correlates of cognitive function in an elderly community population. Am J Epidemiol (1988) 2.26
Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS. Honolulu-Asia aging Study. Neurobiol Aging (2000) 2.26
Association of vitamin E and C supplement use with cognitive function and dementia in elderly men. Neurology (2000) 2.26
Brain aging and midlife tofu consumption. J Am Coll Nutr (2000) 2.25
Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham Study. Neurology (1993) 2.21
Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men. The Honolulu-Asia aging study. Arterioscler Thromb Vasc Biol (2000) 2.16
Accuracy of clinical criteria for AD in the Honolulu-Asia Aging Study, a population-based study. Neurology (2001) 2.15